Pelthos Therapeutics sells FDA approved prescription skin treatments for molluscum contagiosum and impetigo from its base in Durham, North Carolina. It last closed at $6.82 on Nov 17, down 3.67% on the day. The average 12-month price target from 3 analysts is $40.00 (+486.5% from the last close), with a high of $59.00 and a low of $21.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).
Each firm's latest rating on PTHS in the past 90 days
Average 12-month target
$40.00
▲ 486.5% upside
Based on 3 analysts who set a price target on PTHS in the past 90 days. The average target is $40.00, with a high of $59.00 and a low of $21.00, compared with the last close of $6.82.
Low $21.00Avg $40.00High $59.00
Blue marker: last close $6.82
Highest target$59.00
Average target$40.00
Lowest target$21.00
Latest rating changes
Piper SandlerReiterated
Nov 13Buy$21
OppenheimerTarget lowered
Nov 13Buy$64 → $59
Lake StreetMaintained
Oct 12Buy$40
OppenheimerMaintained
Aug 14Buy$64
Date
Firm
Action
Rating
Price target
Nov 13
Piper Sandler
Reiterated
Buy
$21
Nov 13
Oppenheimer
Target lowered
Buy
$64 → $59
Oct 12
Lake Street
Maintained
Buy
$40
Aug 14
Oppenheimer
Maintained
Buy
$64
Loading…
Technical Analysis
PTHS · as of the Nov 17 close · updated after every close
Downtrend, oversold
The stock is 72% below its 20 day and 156% below its 50 day average. It is 241% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 24), oversold. The nearest support is the 52 week low at $6.76, and the nearest resistance the Pivot at $6.88.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 22.7%/day
Key levels
$34.6852 week high+408.5%
$23.26200 day average+241.1%
$22.07100 day average+223.6%
$20.50Swing high (Oct 30)+200.6%
$17.4650 day average+156.0%
$11.7420 day average+72.1%
$7.00Pivot R1+2.6%
$6.88Pivot+0.9%
$6.82Last close
$6.7652 week low−0.9%
$6.70Pivot S1−1.8%
Indicators
RSI (14)
24.24
Oversold below 30
Oversold
MACD
-3.24
Below its signal line
Bearish
Stochastic
0.5
Near the bottom of its range
Oversold
ADX (14)
49.4
Strong downtrend
Williams %R
-99.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-98.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−36.0%
Change over 10 sessions
Bearish
ATR (14)
$1.55
Typical daily range, 22.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityHigh, 52.8%/day
Key levels
$34.6852 week high+408.5%
$23.26200 day average+241.1%
$22.07100 day average+223.6%
$20.50Swing high (Oct 30)+200.6%
$17.4650 day average+156.0%
$11.7420 day average+72.1%
$7.00Pivot R1+2.6%
$6.88Pivot+0.9%
$6.82Last close
$6.7652 week low−0.9%
$6.70Pivot S1−1.8%
Indicators
RSI (14)
19.13
Oversold below 30
Oversold
MACD
-4.32
Below its signal line
Bearish
Stochastic
0.9
Near the bottom of its range
Oversold
ADX (14)
34.6
Trending down
Williams %R
-99.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-184.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−68.9%
Change over 10 sessions
Bearish
ATR (14)
$3.60
Typical daily range, 52.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for PTHS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PTHS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90D
No whale options trades in PTHS in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PTHS is in one of them and how their past PTHS trades turned out.
Pelthos Therapeutics is a biopharmaceutical company based in Durham, North Carolina. It sells prescription skin treatments that have been approved by the U.S. Food and Drug Administration. Its main products are ZELSUVMI, a topical gel for molluscum contagiosum, a common viral skin infection, and XEPI, a cream for impetigo, a bacterial skin infection. The products are used by patients, parents and caregivers, and are prescribed by dermatologists and pediatricians.